XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Notes Receivable From Stockholders
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at beginning of period at Jun. 30, 2020 $ 31 $ 374,399 $ (90) $ (1,631) $ (338,068) $ 34,641
Balance at beginning of period (in shares) at Jun. 30, 2020 30,821          
Interest on stockholder's notes     (2)     (2)
Issuance of common stock upon exercise of stock options   944       944
Issuance of common stock upon exercise of stock options (in shares) 214          
Issuance of common stock in connection with employee stock purchase plan   508       508
Issuance of common stock in connection with employee stock purchase plan (in shares) 57          
Stock-based compensation   1,264       1,264
Foreign currency translation adjustments       323   323
Net (loss) income         4,911 4,911
Balance at end of period at Mar. 31, 2021 $ 31 377,115 (92) (1,308) (333,157) 42,589
Balance at end of period (in shares) at Mar. 31, 2021 31,092          
Balance at beginning of period at Dec. 31, 2020 $ 31 376,546 (91) (1,270) (334,418) 40,798
Balance at beginning of period (in shares) at Dec. 31, 2020 31,048          
Interest on stockholder's notes     (1)     (1)
Issuance of common stock upon exercise of stock options   201       201
Issuance of common stock upon exercise of stock options (in shares) 44          
Stock-based compensation   368       368
Foreign currency translation adjustments       (38)   (38)
Net (loss) income         1,261 1,261
Balance at end of period at Mar. 31, 2021 $ 31 377,115 (92) (1,308) (333,157) 42,589
Balance at end of period (in shares) at Mar. 31, 2021 31,092          
Balance at beginning of period at Jun. 30, 2021 $ 31 378,451 (92) (1,220) (331,109) 46,061
Balance at beginning of period (in shares) at Jun. 30, 2021 31,231          
Interest on stockholder's notes     (3)     (3)
Issuance of common stock upon exercise of stock options   2,042       2,042
Issuance of common stock upon exercise of stock options (in shares) 525          
Issuance of common stock in connection with employee stock purchase plan   558       558
Issuance of common stock in connection with employee stock purchase plan (in shares) 65          
Stock-based compensation   8,936       8,936
Foreign currency translation adjustments       (445)   (445)
Net (loss) income         (890) (890)
Balance at end of period at Mar. 31, 2022 $ 31 389,987 (95) (1,665) (331,999) 56,259
Balance at end of period (in shares) at Mar. 31, 2022 31,821          
Balance at beginning of period at Dec. 31, 2021 $ 31 385,467 (94) (1,356) (331,384) 52,664
Balance at beginning of period (in shares) at Dec. 31, 2021 31,493          
Interest on stockholder's notes     (1)     (1)
Issuance of common stock upon exercise of stock options   1,512       1,512
Issuance of common stock upon exercise of stock options (in shares) 328          
Stock-based compensation   3,008       3,008
Foreign currency translation adjustments       (309)   (309)
Net (loss) income         (615) (615)
Balance at end of period at Mar. 31, 2022 $ 31 $ 389,987 $ (95) $ (1,665) $ (331,999) $ 56,259
Balance at end of period (in shares) at Mar. 31, 2022 31,821